Model based on five tumour immune microenvironment-related genes for predicting hepatocellular carcinoma immunotherapy outcomes
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Model based on five tumour immune microenvironment-related genes for predicting hepatocellular carcinoma immunotherapy outcomes
Authors
Keywords
-
Journal
Journal of Translational Medicine
Volume 19, Issue 1, Pages -
Publisher
Springer Science and Business Media LLC
Online
2021-01-07
DOI
10.1186/s12967-020-02691-4
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Prediction of hepatocellular carcinoma prognosis based on expression of an immune-related gene set
- (2020) Yuting He et al. Aging-US
- PFKFB4 negatively regulated the expression of histone acetyltransferase GCN5 to mediate the tumorigenesis of thyroid cancer
- (2020) Huanquan Lu et al. DEVELOPMENT GROWTH & DIFFERENTIATION
- Prognostic role of tumor mutation burden in hepatocellular carcinoma after radical hepatectomy
- (2020) Huayong Cai et al. JOURNAL OF SURGICAL ONCOLOGY
- Dissecting the spatial heterogeneity of different immune cell subsets in non-small cell lung cancer
- (2020) Philipp Jurmeister et al. PATHOLOGY RESEARCH AND PRACTICE
- ImmuCellAI: A Unique Method for Comprehensive T‐Cell Subsets Abundance Prediction and its Application in Cancer Immunotherapy
- (2020) Ya‐Ru Miao et al. Advanced Science
- Integrative Analysis of Multi-omics Data Identified EGFR and PTGS2 as Key Nodes in a Gene Regulatory Network Related to Immune Phenotypes in Head and Neck Cancer
- (2020) Bohai Feng et al. CLINICAL CANCER RESEARCH
- PFKFB4 is critical for the survival of acute monocytic leukemia cells
- (2020) Gongai Wang et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Identification and Validation of Novel Biomarkers for Diagnosis and Prognosis of Hepatocellular Carcinoma
- (2020) Xiaoyi Hu et al. Frontiers in Oncology
- Tumor mutational burden (TMB) standardization initiatives: Recommendations for consistent TMB assessment in clinical samples to guide immunotherapy treatment decisions
- (2019) Albrecht Stenzinger et al. GENES CHROMOSOMES & CANCER
- Identification of a six-gene signature predicting overall survival for hepatocellular carcinoma
- (2019) Gao-Min Liu et al. Cancer Cell International
- Immune cell therapy for hepatocellular carcinoma
- (2019) Eishiro Mizukoshi et al. Journal of Hematology & Oncology
- High expression of metabolic enzyme PFKFB4 is associated with poor prognosis of operable breast cancer
- (2019) Ling Yao et al. Cancer Cell International
- Clinical impact of genomic diversity from early to advanced hepatocellular carcinoma
- (2019) Jean-Charles Nault et al. HEPATOLOGY
- Clinical immunology and immunotherapy for hepatocellular carcinoma: current progress and challenges
- (2019) Lifeng Wang et al. Hepatology International
- MTA1 coregulator regulates LDHA expression and function in breast cancer
- (2019) Rohith Kumar Guddeti et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- An independent poor-prognosis subtype of breast cancer defined by a distinct tumor immune microenvironment
- (2019) Xavier Tekpli et al. Nature Communications
- miR-142-3p inhibits aerobic glycolysis and cell proliferation in hepatocellular carcinoma via targeting LDHA
- (2018) Shengni Hua et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- LDHA upregulation independently predicts poor survival in lung adenocarcinoma, but not in lung squamous cell carcinoma
- (2018) Chengyong Yu et al. Future Oncology
- Development of a new patient-derived xenograft humanised mouse model to study human-specific tumour microenvironment and immunotherapy
- (2018) Yue Zhao et al. GUT
- LDHA is a direct target of miR-30d-5p and contributes to aggressive progression of gallbladder carcinoma
- (2018) Yuting He et al. MOLECULAR CARCINOGENESIS
- Cancer immunotherapy: broadening the scope of targetable tumours
- (2018) Jitske van den Bulk et al. Open Biology
- Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
- (2018) Freddie Bray et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Metabolic enzyme PFKFB4 activates transcriptional coactivator SRC-3 to drive breast cancer
- (2018) Subhamoy Dasgupta et al. NATURE
- TGFβ attenuates tumour response to PD-L1 blockade by contributing to exclusion of T cells
- (2018) Sanjeev Mariathasan et al. NATURE
- Immune cell infiltration as a biomarker for the diagnosis and prognosis of stage I–III colon cancer
- (2018) Rui Zhou et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Insilico structure modeling and molecular docking analysis of phosphoribosyl pyrophosphate amidotransferase (PPAT) with antifolate inhibitors
- (2018) Nousheen Bibi et al. CURRENT CANCER DRUG TARGETS
- Large-scale analysis reveals a novel risk score to predict overall survival in hepatocellular carcinoma
- (2018) Yujia Zheng et al. Cancer Management and Research
- Evaluation and prediction of hepatocellular carcinoma prognosis based on molecular classification
- (2018) Kun Ke et al. Cancer Management and Research
- Development and validation of an immune gene-set based Prognostic signature in ovarian cancer
- (2018) Sipeng Shen et al. EBioMedicine
- Identification of an Immune-specific Class of Hepatocellular Carcinoma, Based on Molecular Features
- (2017) Daniela Sia et al. GASTROENTEROLOGY
- Histological subtypes of hepatocellular carcinoma are related to gene mutations and molecular tumour classification
- (2017) Julien Calderaro et al. JOURNAL OF HEPATOLOGY
- LDHA promotes tumor metastasis by facilitating epithelial-mesenchymal transition in renal cell carcinoma
- (2017) Juping Zhao et al. Molecular Medicine Reports
- Elements of cancer immunity and the cancer–immune set point
- (2017) Daniel S. Chen et al. NATURE
- Tumor Mutational Burden and Response Rate to PD-1 Inhibition
- (2017) Mark Yarchoan et al. NEW ENGLAND JOURNAL OF MEDICINE
- Analysis of 100,000 human cancer genomes reveals the landscape of tumor mutational burden
- (2017) Zachary R. Chalmers et al. Genome Medicine
- Conservation of immune gene signatures in solid tumors and prognostic implications
- (2016) Julia Chifman et al. BMC CANCER
- Frequently mutated genes/pathways and genomic instability as prevention targets in liver cancer
- (2016) Chinthalapally V. Rao et al. CARCINOGENESIS
- Evidence-Based Diagnosis, Staging, and Treatment of Patients With Hepatocellular Carcinoma
- (2016) Jordi Bruix et al. GASTROENTEROLOGY
- Immunological Microenvironment of Hepatocellular Carcinoma and Its Clinical Implication
- (2016) Naoshi Nishida et al. ONCOLOGY
- Challenges of advanced hepatocellular carcinoma
- (2016) Stefano Colagrande et al. WORLD JOURNAL OF GASTROENTEROLOGY
- Epigenetic modifications promote the expression of the orphan nuclear receptor NR0B1 in human lung adenocarcinoma cells
- (2016) Yongjie Lu et al. Oncotarget
- Molecular and Genetic Properties of Tumors Associated with Local Immune Cytolytic Activity
- (2015) Michael S. Rooney et al. CELL
- Exome sequencing of hepatocellular carcinomas identifies new mutational signatures and potential therapeutic targets
- (2015) Kornelius Schulze et al. NATURE GENETICS
- Prognostic significance of kynurenine 3-monooxygenase and effects on proliferation, migration and invasion of human hepatocellular carcinoma
- (2015) Haojie Jin et al. Scientific Reports
- Telomerase reverse transcriptase promoter mutation is an early somatic genetic alteration in the transformation of premalignant nodules in hepatocellular carcinoma on cirrhosis
- (2014) Jean Charles Nault et al. HEPATOLOGY
- Trans-ancestry mutational landscape of hepatocellular carcinoma genomes
- (2014) Yasushi Totoki et al. NATURE GENETICS
- High-throughput epitope discovery reveals frequent recognition of neo-antigens by CD4+ T cells in human melanoma
- (2014) Carsten Linnemann et al. NATURE MEDICINE
- Mechanisms of regulation of PFKFB expression in pancreatic and gastric cancer cells
- (2014) Oleksandr H Minchenko WORLD JOURNAL OF GASTROENTEROLOGY
- Integrated analysis of somatic mutations and focal copy-number changes identifies key genes and pathways in hepatocellular carcinoma
- (2012) Cécile Guichard et al. NATURE GENETICS
- RNAi screening in glioma stem-like cells identifies PFKFB4 as a key molecule important for cancer cell survival
- (2011) V Goidts et al. ONCOGENE
- PFKFB4 as a prognostic marker in non-muscle-invasive bladder cancer
- (2011) Seok Joong Yun et al. UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS
- Decreased expression of PinX1 protein is correlated with tumor development and is a new independent poor prognostic factor in ovarian carcinoma
- (2010) Mu-Yan Cai et al. CANCER SCIENCE
- EWS/FLI and Its Downstream Target NR0B1 Interact Directly to Modulate Transcription and Oncogenesis in Ewing's Sarcoma
- (2009) M. Kinsey et al. CANCER RESEARCH
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started